0
Department of Health and Human Services Awarded a Contract to THE TRUSTEES OF PRINCETON UNIVERSITY for $2,692,771.30
Signed on
9/29/2022, 12:00 AM
THE TRUSTEES OF PRINCETON UNIVERSITY Government Contract #75F40122C00186
THE TRUSTEES OF PRINCETON UNIVERSITY was awarded a contract with the United States Government for $2,692,771.30. The contract was awarded by the agency office FDA OFFICE OF ACQ GRANT SVCS, which is a division with the Food and Drug Administration within the Department of Health and Human Services.
Summary of Award
The US federal government awarded a contract with the generated unique award ID CONT_AWD_75F40122C00186_7524_-NONE-_-NONE- for an integrated platform for continuous RNA nanoparticle formulation and drying. The total obligation for this contract is $2,692,771.30, with 7 subawards totaling $2,926,900. The contract was signed on September 29, 2022, and includes base exercised options of $2,692,771.30. The total account outlay is $1,335,161.94, and the total account obligation is $2,692,771.30.
The contract falls under the category of a definitive contract (type D) and was solicited under FDABAA2200123 with negotiated proposal/quote procedures. There were 165 offers received, and the extent competed was full and open competition. The contract does not have a set-aside used and does not involve small business competitive preferences. The product or service code is AN11, and the NAICS code is 541714 for research and development in biotechnology.
The funding agency for this contract is the Department of Health and Human Services, specifically the Food and Drug Administration (FDA) office of acquisition and grant services. The period of performance for this contract is from September 29, 2022, to March 31, 2025, with a potential end date of March 31, 2025.
The recipient of the contract is The Trustees of Princeton University, located in Princeton, New Jersey. They are a tax-exempt educational institution classified as a nonprofit organization and higher education provider. The contract is for health research and development services, health care services, and basic research. The recipient's business categories include Category Business, Corporate Entity Tax Exempt, Educational Institution, Higher Education, Nonprofit Organization, and Higher Education (Private).
The place of performance for this contract is also in Princeton, New Jersey, with the primary focus on research and development in the health sector. The contract is classified under the Professional, Scientific, and Technical Services sector, specifically in scientific research and development services.
Overall, this contract highlights the collaboration between the US federal government and The Trustees of Princeton University to advance research and development in biotechnology, specifically in the area of continuous RNA nanoparticle formulation and drying. The contract aims to support innovative solutions in the health sector and contribute to the advancement of scientific knowledge and technology.